Table 2 The clinical characteristics in mean (± SD) of people with PD participants
From: Muscle activation strategies of people with early-stage Parkinson’s during walking
Clinical variables | PD |
|---|---|
Disease duration (years) | 4.27 ± 3.15 |
Time since last medication (hours) | 3.67 ± 1.68 |
UPDRS III | 25.69 ± 10.95 |
UPDRS PIGD subscore | 5.29 ± 3.07 |
H &Y scale | 2.27 ± 0.94 |
Levodopa dosage mg/day | 456.72 ± 148.23 |
Range of H &Y scale | 1–3 |
Tremor at rest (lower limb) | 0.125 ± 0.33 |
UPDRS rigidity (Item 3.3) | 1.16 ± 0.83 |
UPDRS leg agility (Item 3.8) | 1.27 ± 0.19 |
UPDRS gait (Item 3.10) | 1.08 ± 0.77 |
UPDRS postural stability (Item 3.12) | 1.41 ± 0.71 |
UPDRS body bradykinesia (Item 3.14) | 1.04 ± 0.75 |